SIONNA THERAPEUTICS, INC. (SION)

SEC filing

SIONNA THERAPEUTICS, INC.

SION · CIK 2036042

4 · Sep 18, 2026 · Director, President & CEO Cloonan Michael was granted 654.15K shares; reported 436.10K Non-Qualified Stock Option (right to buy)

Director, President & CEO Cloonan Michael was granted 654.15K shares; reported 436.10K Non-Qualified Stock Option (right to buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.